Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PCVX compared with ASND: revenue, margins and what each company keeps, and the suppliers and customers both name
PCVX
Vaxcyte, Inc.
Change
Mkt cap
Revenue
Revenue
ASND
Ascendis Pharma A/S
Change
Mkt cap
Revenue
Revenue
vs
Compare
PCVX
Vaxcyte, Inc.
vs
ASND
Ascendis Pharma A/S
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
PCVX
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±10.2%
▼
−5.72%
×0.56
Q2 FY26
±8.6%
▲
+5.31%
×0.62
May 7 '26
±7.2%
▼
−9.84%
×1.36
Q1 FY26
±10.5%
▲
+2.75%
×0.27
ASND
No earnings history for ASND.
= implied
PCVX realized, solid
ASND realized, hatched
One scale, both sides: full bar = 11%
× = |realized| ÷ implied
Source: market data
PCVX
Vaxcyte, Inc.
Change
61.92
· pre 61.85
· delayed
Mkt cap
$10.4B
ASND
Ascendis Pharma A/S
Change
252.53
· pre 253.00
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$15.7B
vs
Compare
Pre-market
Nov 6 '26
delayed
PCVX
Vaxcyte, Inc.
vs
ASND
Ascendis Pharma A/S
61.92
pre 61.85
delayed
Price
252.53
pre 253.00
delayed
$10.4B
Mkt cap
$15.7B
Change
Change
PCVX
61.92
vs
ASND
252.53
Pre-market
Nov 6 '26
delayed